Search results

Assay proposed for the measurement of TAFI in research applications.

High TAFI Ag concentrations involve a hypofibrinolytic status, which can induce an elevated risk of thrombosis. Measurement of TAFI Ag on plasma in order to diagnose a risk of a hypofibrinolysis resulting from an excess of TAFI.

For any in vitro protocol or research study where a source of human TAFI deficient plasma is required.

Supplied with full step-by-step instructions for performing sandwich ELISAs. For research use only.

For any in vitro protocol or research study where a source of human TAFI deficient plasma is required.

Test reagents for quick and efficient measurement of the Global Fibrinolytic Capacity with Hyphen BioMed's lysis timer .

CRYO check ™ Abnormal 1 Control is recommended for use as abnormal controls for PT and aPTT assays. Contains reduced levels of clotting factors II, VII, IX and X.

CRYO check ™ Abnormal 2 Control is recommended for use as abnormal controls for PT and aPTT assays. Contains strongly reduced levels of clotting factors II, VII, IX and X.

For research use only.

Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.